BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1377490)

  • 1. Transfection of HLA-DR-expressing DAP.3 cells with a cDNA clone encoding the glycosyl phosphatidylinositol-linked form of lymphocyte function associated antigen-3: biochemical features and functional consequences.
    Greenlaw R; Robinson P; Heaton T; Lombardi G; Lechler R
    Int Immunol; 1992 Jun; 4(6):673-80. PubMed ID: 1377490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
    Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
    J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micromanipulation of adhesion of a Jurkat cell to a planar bilayer membrane containing lymphocyte function-associated antigen 3 molecules.
    Tözeren A; Sung KL; Sung LA; Dustin ML; Chan PY; Springer TA; Chien S
    J Cell Biol; 1992 Feb; 116(4):997-1006. PubMed ID: 1370839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
    Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
    Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes.
    Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE
    J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2.
    Chan PY; Lawrence MB; Dustin ML; Ferguson LM; Golan DE; Springer TA
    J Cell Biol; 1991 Oct; 115(1):245-55. PubMed ID: 1717480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.
    Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP
    J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3.
    Dustin ML; Olive D; Springer TA
    J Exp Med; 1989 Feb; 169(2):503-17. PubMed ID: 2463330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor.
    Bockenstedt LK; Goldsmith MA; Dustin M; Olive D; Springer TA; Weiss A
    J Immunol; 1988 Sep; 141(6):1904-11. PubMed ID: 2459194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen.
    Koyasu S; Lawton T; Novick D; Recny MA; Siliciano RF; Wallner BP; Reinherz EL
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2603-7. PubMed ID: 1690889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
    Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
    Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional CD2 mutants unable to bind to, or be stimulated by, LFA-3.
    Wolff HL; Burakoff SJ; Bierer BE
    J Immunol; 1990 Feb; 144(4):1215-20. PubMed ID: 1689346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for both the CD3/T cell receptor complex and the CD2/lymphocyte function-associated antigen-3 adhesion system in monocyte-independent T cell activation by oxidized erythrocytes.
    Prince HE
    Immunol Invest; 1989; 18(9-10):1081-93. PubMed ID: 2482251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.
    Weber F; Meinl E; Aloisi F; Nevinny-Stickel C; Albert E; Wekerle H; Hohlfeld R
    Brain; 1994 Feb; 117 ( Pt 1)():59-69. PubMed ID: 7511974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of T cell activation and adhesion functions by soluble CD2 protein.
    Rabin EM; Gordon K; Knoppers MH; Luther MA; Neidhardt EA; Flynn JF; Sardonini CA; Sampo TM; Concino MF; Recny MA
    Cell Immunol; 1993 Jun; 149(1):24-38. PubMed ID: 7685660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins.
    Bierer BE; Golan DE; Brown CS; Herrmann SH; Burakoff SJ
    Eur J Immunol; 1989 Apr; 19(4):661-5. PubMed ID: 2471647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23.
    Staunton DE; Fisher RC; LeBeau MM; Lawrence JB; Barton DE; Francke U; Dustin M; Thorley-Lawson DA
    J Exp Med; 1989 Mar; 169(3):1087-99. PubMed ID: 2466936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxins.
    Mittrücker HW; Fleischer B
    Cell Immunol; 1992 Jan; 139(1):108-17. PubMed ID: 1370253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LFA-3 adhesion pathway is differently utilized by superantigen-activated human CD4+ T-cell subsets.
    Gjörloff A; Hedlund G; Kalland T; Sansom D; Fischer H; Trowsdale J; Sjögren HO; Dohlsten M
    Scand J Immunol; 1992 Aug; 36(2):243-50. PubMed ID: 1380180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.